Gastric cancer is one of the leading causes of cancer-related death worldwide. Many
patients have inoperable disease at diagnosis or have recurrent disease after resection with …

Purpose This systematic review and meta-analysis were performed to assess the efficacy
and tolerability of chemotherapy in patients with advanced gastric cancer. Methods …

BACKGROUND: The value of second-line therapy for metastatic gastric cancer is unclear.
So far there are no randomised phase III data comparing second-line chemotherapy to best …

Background We aimed to establish the superiority (or noninferiority if superiority was not
achieved) in terms of time to progression (TTP) of irinotecan/5-fluorouracil (IF) over …

BACKGROUND: Gastric cancer remains a major health problem worldwide. Treatment of
advanced gastric cancer is controversial and there is no standard regimen for first-or second …

Purpose To determine the efficacy and safety of a biweekly regimen of leucovorin (LV) plus
fluorouracil (FU) alone or in combination with cisplatin or irinotecan in patients with …

Background: The purpose of this phase II study was to evaluate the efficacy and safety of
cetuximab combined with FOLFIRI as a first-line treatment of advanced gastric or …

A highly efficient electrochemical sensor for the analysis of anticancer drug 5-fluorouracil (5-
FU), is fabricated based on silver nanoparticles-polyaniline nanotube (AgNPs@ PANINTs) …

Background To identify the most effective of two combinations, irinotecan/5-fluorouracil (5-
FU)/folinic acid (FA) and irinotecan/cisplatin, in the treatment of advanced gastric cancer, for …

Surgery is the main treatment for curing gastric cancer. Early diagnosis provides an
excellent survival outcome via an improved detection of early gastric cancer and an …